JLE

Epileptic Disorders

MENU

Bone mineral density following long-term use of antiepileptic drugs in a tropical Asian country Volume 10, numéro 3, September 2008

Andress et al 2002 Andress DL, Ozuna J, Tirschwell D, et al. Antiepileptic drug induced bone loss in young male patients who have seizures. Arch Neurol 2002; 59: 781-6.

Berr et al 1983 Berr JL, Mawer M, Walker DA. Effect of antiepileptic drug therapy and expose to sunlight on vitamin D status in institutionalized patients. In: Oxley J, ed. Chronic toxicity of antiepileptic drugs. New York: Raven Press, 1983: 185-91.

Boluk et al 2004 Boluk A, Guzelipek M, Savli H, et al. The effect of valproate on bone mineral density in adult epileptic patients. Pharmacol Res 2004; 50: 93-7.

Brämswing et al 2003 Brämswing S, Zittermann A, Berthod HK. Carbamazepine does not alter biochemical parameters of bone turnover in healthy male adult. Calcif Tissue Int 2003; 73: 356.

Christiansen et al 1973 Christiansen C, Rodbro P, Lund M. Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial. BMJ 1973; 4: 695-701.

Craven and Hawks, 2006 Craven KL, Hawks SR. Cultural and western influences on the nutrition transition in Thailand. Promot Educ 2006; 13: 14-20.

Cummings et al 1995 Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporptic Fractures Research Group. N Engl J Med 1995; 332: 767-73.

Ecevit et al 2004 Ecevit C, Aydoğan A, Kavakli T, et al. Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol 2004; 31: 279-82.

Elliott and Jacobson, 2006 Elliott JO, Jacobson MP. Bone loss in epilepsy: barriers to prevention, diagnosis, and treatment. Epilepsy Behav 2006; 8: 169-75.

Elliott et al 2007 Elliott JO, Jacobson MP, Haneef Z. Homocysteine and bone loss in epilepsy. Seizure 2007; 16: 22-34.

Engel, 2001 Engel Jr J. International League Against Epilepsy (ILAE). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001; 42: 796-803.

Farhat et al 2002 Farhat G, Yamout B, Mikati MA, et al. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002; 58: 1348-53.

Gilsanz et al 1998 Gilsanz V, Skaggs DL, Kovanlikaya A, et al. Differential effect of race on the axial and appendicular skeletons of children. J Clin Endocrinol Metab 1998; 83: 1420-7.

Hahn et al 1972 Hahn TJ, Hendin BA, Scharp CR, et al. Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. N Engl J Med 1972; 287: 900-4.

Jaglal et al 1995 Jaglal SB, Kreiger N, Darlington GA. Lifetime occupational physical activity and risk of hip fracture in woman. Ann Epidemiol 1995; 5: 321-4.

Kajadphai-Taungbodhitham, 2007 Kajadphai-Taungbodhitham A. Composition of ready cooked foods sampled in southern Thailand. Asia Pac J Clin Nutr 2007; 16(Suppl. 1): 52-7.

Kanis et al 1996 Kanis JA, Devogelaer JP, Gennari C. Practical guide for the use of bone mineral measurements in the assessment of treatment of osteoporosis: a position paper of the European foundation for osteoporosis and bone disease. The Scientific Advisory Board and the Board of National Societies. Osteoporos Int 1996; 6: 256-61.

Kim et al 2007 Kim SH, Lee JW, Choi KG, et al. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Epilepsia Behav 2007; 10: 291-5.

Kulak et al 2004 Kulak CA, Borba VZ, Bilezikian JP, et al. Bone mineral density and serum levels of 25-OH vitamin D in chronic users of antiepileptic drugs. Arq Neuropsiquiatr 2004; 62: 940-8.

Kulak et al 2007 Kulak CA, Borba VZ, Silvado CE, et al. Bone density and bone turnover markers in patients with epilepsy on chronic antiepileptic drug therapy. Arq Bras Endocrinol Metabol 2007; 51: 466-71.

Marshall et al 1996 Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312: 1254-9.

Matsuda-Inuguchi et al 2000 Matsuda-Inuguchi N, Shimbo S, Zhang ZW, et al. Nutrient intake of working woman in Bangkok, Thailand, as studies by total food duplicate method. Eur J Clin Nutr 2000; 54: 187-94.

Mosekilde et al 1977 Mosekilde L, Christensen MS, Lund B, et al. The interrelationships between serum 25-hydroxycholcalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia. Acta Endocrinol (Copenh) 1977; 84: 559-65.

Nelson et al 1997 Nelson DA, Simpson PM, Johnson CC, et al. The accumulation of whole body skeletal mass in third- and fourth-grade children: effects of age, gender, ethnicity, and body composition. Bone 1997; 20: 73-8.

Pack et al 2003 Pack AM, Olarte LS, Morrell MJ, et al. Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav 2003; 4: 169-74.

Pack et al 2005 Pack AM, Morrell MJ, Marcus R, et al. Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol 2005; 57: 252-7.

Pascussi et al 2005 Pascussi JM, Robert A, Nguyen M, et al. Possible involvement of pregnane X receptor-Enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest 2005; 115: 177-86.

Petty et al 2005 Petty SJ, Paton LM, O’Brien TJ, et al. Effect of antiepileptic medication on bone mineral measures. Neurology 2005; 65: 1358-63.

Richens and Rowe, 1970 Richens A, Rowe DJ. Disturbance of calcium metabolism by anticonvulsant drugs. BMJ 1970; 4: 73-6.

Sato et al 2001 Sato Y, Kondo I, Ishida S. decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 2001; 57: 445-9.

Sheth et al 1995 Sheth RD, Wesolowski CA, Jacop JC, et al. Effect of carbamazepine and valproate on bone mineral density. J Pediatr 1995; 127: 256-62.

Sheth, 2002 Sheth RD. Bone health in epilepsy. Epilepsia 2002; 43: 1453-4.

Stephen et al 1999 Stephen LJ, McLellan AR, Harrison JH, et al. Bone density and antiepileptic drugs: a case controlled study. Seizure 1999; 8: 339-42.

Sukalakemala and Brittin, 2006 Sukalakemala S, Brittin HC. Food practices, change, preferences, and acculturation of Thais in the United States. J Am Diet Assoc 2006; 106: 103-8.

Tekgul et al 2006 Tekgul H, Serdaroglu G, Huseyinov A, et al. Bone mineral status in pediatric outpatients on antiepileptic drug monotherapy. J Child Neurol 2006; 21: 411-4.

Tjellesen and Christiansen, 1982 Tjellesen L, Christiansen C. Serum vitamin D metabolites in epileptic patients treated with 2 different anti-convulsants. Acta Neurol Scand 1982; 66: 335-41.

Tolman et al 1975 Tolman KG, Jubiz W, Sannella JJ, et al. Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children. Pediatrics 1975; 56: 45-50.

Verrotti et al 2000 Verrotti A, Greco R, Morgese G, et al. Increased bone turnover in epileptic Patients treated with carbamazepine. Ann Neurol 2000; 47: 385-8.

Verrotti et al 2002 Verrotti A, Greco R, Latini G, et al. Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia 2002; 43: 1488-92.

Vestergaard et al 1999 Vestergaard P, Tigaran S, Rejnmark L, et al. Fracture risk is increased in epilepsy. Acta Neurol Scand 1999; 99: 269-75.

World Health Organization, 2000 World Health Organization, International Association for the Study of Obesity, International Obesity Task Force. The Asia-Pacific Perspective: Redefining obesity and its treatment. Sydney: Health Communications, 2000.

Wang et al 1997 Wang MC, Aguirre M, Bhudhikanok GS, et al. Bone mass and hip axis length in healthy Asian, black, Hispanic, and white American youths. J Bone Miner Res 1997; 12: 1922-35.